Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $166.2M | -- | -- | $0.27 | -- |
| 11/05/2025 | Q3 | $160.5M | $165.9M | $0.17 | $0.28 | -$0.11 |
| 08/06/2025 | Q2 | $151.3M | $166.1M | $0.20 | $0.23 | -$0.03 |
| 05/07/2025 | Q1 | $166M | $167.3M | $0.20 | $0.32 | -$0.12 |
| 02/12/2025 | Q4 | $176.3M | $182.1M | $0.26 | $0.40 | -$0.15 |
| 11/06/2024 | Q3 | $180.6M | $184.8M | $0.36 | $0.45 | -$0.09 |
| 08/06/2024 | Q2 | $176M | $175.9M | $0.25 | $0.43 | -$0.18 |
| 05/07/2024 | Q1 | $170.6M | $174.5M | $0.37 | $0.41 | -$0.04 |
| 02/14/2024 | Q4 | $169.1M | $173.9M | $0.36 | $0.42 | -$0.06 |
| 11/06/2023 | Q3 | $168.2M | $177.4M | $0.42 | $0.37 | $0.05 |
| 08/07/2023 | Q2 | -- | $161.6M | -$1.61 | -- | -- |
| 05/08/2023 | Q1 | -- | $153.5M | $0.17 | -- | -- |
| 02/15/2023 | Q4 | -- | $153.8M | $2.01 | -- | -- |
| 11/07/2022 | Q3 | -- | $171.9M | $0.27 | -- | -- |
| 08/08/2022 | Q2 | -- | $164M | $0.18 | -- | -- |
| 05/09/2022 | Q1 | -- | $156.4M | $0.20 | -- | -- |
| 02/16/2022 | Q4 | -- | $153M | $0.15 | -- | -- |
| 11/02/2021 | Q3 | -- | $150.2M | $0.17 | -- | -- |
| 08/03/2021 | Q2 | -- | $146.3M | $0.12 | -- | -- |
| 05/04/2021 | Q1 | -- | $133.7M | $0.05 | -- | -- |
| 02/11/2021 | Q4 | -- | $138.9M | -$0.00 | -- | -- |
| 10/27/2020 | Q3 | -- | $112.1M | $0.01 | -- | -- |
| 08/03/2020 | Q2 | -- | $98.6M | -$0.17 | -- | -- |
| 05/07/2020 | Q1 | -- | $104.5M | -$0.01 | -- | -- |
| 02/13/2020 | Q4 | -- | $113.2M | -$0.69 | -- | -- |
| 11/04/2019 | Q3 | -- | $109M | -$0.25 | -- | -- |
| 08/05/2019 | Q2 | -- | $97.8M | -$0.33 | -- | -- |
| 05/06/2019 | Q1 | -- | $99.4M | -$0.40 | -- | -- |
| 02/11/2019 | Q4 | -- | $99M | -$3.11 | -- | -- |
| 11/01/2018 | Q3 | -- | $126.8M | -$0.19 | -- | -- |
| 08/02/2018 | Q2 | -- | $157.8M | -$5.02 | -- | -- |
| 05/07/2018 | Q1 | -- | $158.6M | -$0.34 | -- | -- |
| 02/12/2018 | Q4 | -- | $139.7M | -$0.18 | -- | -- |
| 11/02/2017 | Q3 | -- | $129.3M | -$0.51 | -- | -- |
| 08/03/2017 | Q2 | -- | $112.2M | -$0.49 | -- | -- |
| 05/04/2017 | Q1 | -- | $94.5M | $0.04 | -- | -- |
| 01/16/2017 | Q4 | -- | $93.6M | -$0.13 | -- | -- |
| 11/01/2016 | Q3 | -- | $85.5M | -$1.78 | -- | -- |
| 08/01/2016 | Q2 | -- | $75.3M | -$0.82 | -- | -- |
| 05/04/2016 | Q1 | -- | $78M | -$0.40 | -- | -- |
| 02/22/2016 | Q4 | -- | $106.5M | -$0.25 | -- | -- |
Veeco Instruments, Inc. reported $165.9M worth of top line sales in its most recent quarter.
Veeco Instruments, Inc. announced earnings per share of $0.17 which represents a miss of analyst forecast a $0.28 per share.
Veeco Instruments, Inc. reported $66.9M that represents $1.10 per share over the last quarter.
Veeco Instruments, Inc.'s earnings are forecast to grow from $1.23 per share to $1.72 per share next year representing an increase of 9.3%.
Veeco Instruments, Inc.'s next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.